"Key Proteins Uncovered as Crucial Drivers of Cancer Cell Growth in Preclinical Study"

A preclinical study led by scientists at City of Hope has identified two cell-surface proteins, integrin αV and β5, as crucial players in promoting cancer cell growth. By targeting the β-propeller domain of integrin αV with a compound called Cpd_AV2, the researchers were able to disrupt the interaction between the two proteins, leading to the halt of cancer cell growth in laboratory experiments. This discovery opens new possibilities for developing targeted therapies and advancing oncologic treatments, offering a promising approach for future cancer medicine studies.